Relaxometry and quantitative susceptibility mapping were used in patients with neurologic symptoms of Wilson disease (WD) that leads to copper metabolism disturbances and its gradual accumulation in liver and brain. These quantitative MR techniques revealed decreased T2 relaxation times in the basal ganglia, higher susceptibility in the deep gray matter nuclei and no T1 changes. It indicates presence of insoluble para- or superparamagnetic compounds, presumably in a form of hemosiderin. These deposits appear to be not related to the ceruloplasmin oxidase activity nor with the severity of neurological symptoms.
This abstract and the presentation materials are available to members only; a login is required.